OXTR and neurodevelopmental disorder: Several mouse models of neurodevelopmental disorders present abnormalities in OXT release and/or OXTR distribution (Meziane et al., 2015; Wagner and Harony-Nicolas, 2018; Borie et al., 2021), providing a strong rationale for the use of OXT as a possible therapeutic agent.